T. Rowe Price Associates’s Nuvectra Corporation Common Stock NVTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-53,643
Closed -$73K 2587
2019
Q3
$73K Sell
53,643
-37,700
-41% -$73.9K ﹤0.01% 2473
2019
Q2
$306K Buy
91,343
+19,502
+27% +$123K ﹤0.01% 2294
2019
Q1
$791K Buy
71,841
+24,410
+51% +$329K ﹤0.01% 1939
2018
Q4
$775K Buy
47,431
+5,120
+12% +$97.9K ﹤0.01% 1910
2018
Q3
$930K Sell
42,311
-9,318
-18% -$179K ﹤0.01% 1905
2018
Q2
$1.06M Buy
51,629
+12,686
+33% +$214K ﹤0.01% 1813
2018
Q1
$507K Sell
38,943
-33,200
-46% -$337K ﹤0.01% 2080
2017
Q4
$560K Buy
72,143
+60
+0.1% +$630 ﹤0.01% 2050
2017
Q3
$956K Sell
72,083
-4,200
-6% -$49.7K ﹤0.01% 1829
2017
Q2
$1.01M Sell
76,283
-1,200
-2% -$11.4K ﹤0.01% 1779
2017
Q1
$529K Sell
77,483
-5,200
-6% -$35.5K ﹤0.01% 2041
2016
Q4
$416K Hold
82,683
﹤0.01% 2130
2016
Q3
$572K Sell
82,683
-23
-0% -$158 ﹤0.01% 1959
2016
Q2
$612K Buy
+82,706
New +$659K ﹤0.01% 1887

Other funds holding NVTR

T. Rowe Price Associates's NVTR Position: Q4 2019 in Review

T. Rowe Price Associates sold out of Nuvectra Corporation Common Stock (NVTR) in Q4 2019, closing a stake of 53,643 shares — an estimated $73K sold.

T. Rowe Price Associates first reported a position in NVTR in Q2 2016 and held it in 14 quarters. The position peaked at $1.06M in Q2 2018. 7 funds tracked by Wall St. Rank hold NVTR as of Q4 2019.

  • T. Rowe Price Associates reported no remaining Nuvectra Corporation Common Stock position as of Q4 2019 after selling out during the quarter.
  • T. Rowe Price Associates sold 53,643 Nuvectra Corporation Common Stock shares in Q4 2019, an estimated $73K.
  • T. Rowe Price Associates first reported a position in Nuvectra Corporation Common Stock in Q2 2016 and held it in 14 quarters.
  • T. Rowe Price Associates's Nuvectra Corporation Common Stock position peaked at $1.06M in Q2 2018.
  • 7 funds tracked by Wall St. Rank held Nuvectra Corporation Common Stock as of Q4 2019.

Based on T. Rowe Price Associates's 13F filing for Q4 2019, filed 14 Feb 2020.